Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference

Rhea-AI Summary

Cocrystal Pharma, Inc. (NASDAQ: COCP) announced a presentation at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020, at 12:00 PM EST. The management team will also hold virtual one-on-one meetings with registered investors at the event. A live video webcast will be accessible through the company's website, with a replay available two hours post-event.

– Live video webcast with the Cocrystal management team, on Thursday, November 12^th at 12:00 PM EST –

BOTHELL, WA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that the Cocrystal management team, will present at the H.C. Wainwright 6^th Annual Israel Conference on Thursday, November 12, 2020 at 12:00 PM EST.

In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

A live video webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website (cocrystalpharma.com). The video webcast replay will be made available two hours following the event.

About Cocrystal Pharma, Inc.

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus. Cocrystal employs unique, proprietary, structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor and Media Contact:

JTC Team, LLC
(833) 475-8247
COCP@jtcir.com

###

FAQ

When is Cocrystal Pharma's presentation at the H.C. Wainwright Conference?

Cocrystal Pharma will present at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020, at 12:00 PM EST.

How can I watch the live webcast of Cocrystal Pharma's presentation?

The live video webcast of Cocrystal Pharma's presentation can be viewed on their website's IR Calendar page.

Will there be investment meetings with Cocrystal Pharma's management team?

Yes, Cocrystal Pharma's management will participate in virtual one-on-one meetings with registered investors during the conference.

What type of therapeutics does Cocrystal Pharma develop?

Cocrystal Pharma develops novel antiviral therapeutics targeting influenza viruses, SARS-CoV-2, hepatitis C, and norovirus.

Where can I find more information about Cocrystal Pharma?

More information about Cocrystal Pharma can be found on their official website, www.cocrystalpharma.com.